Join a leading global record label in the vibrant city of Cologne as a Frontend Developer specializing in Vue and ...

Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

A widely prescribed medication for underactive thyroid, levothyroxine, is potentially associated with bone loss, according to a study set for presentation at the Radiological Society of North ...

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented ...

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasize the need to ...

New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old ...

After an average follow-up period of 6.3 years, older adults on levothyroxine had a greater loss of both total body bone mass and bone density.